ACID PHOSPHATASE - PROSTATIC FRACTION (ACP- PROSTATIC)

Acid Phosphatase – Prostatic Fraction (ACP-Prostatic), also known as Prostatic Acid Phosphatase (PAP), is a blood test that measures the prostate-associated fraction of acid phosphatase. Acid phosphatases are enzymes found in different tissues, while the prostatic fraction is produced mainly by epithelial cells of the prostate gland.

Prostatic acid phosphatase was historically used as a tumour marker for prostate cancer. It is no longer considered the preferred test for prostate cancer screening or initial staging because prostate-specific antigen (PSA) generally provides more clinically useful information. However, PAP may still be requested in selected cases as a supportive marker, particularly for monitoring known prostate cancer or assessing response to certain treatments.

Benefits of the Test

• Measures the prostate-associated fraction of acid phosphatase.
• Provides supportive biochemical information about selected prostate conditions.
• May assist in monitoring patients with known prostate cancer.
• May help assess disease progression or recurrence in selected cases.
• Can support evaluation of response to androgen-deprivation treatment.
• May provide additional prognostic information in specific clinical situations.
• Can be interpreted together with PSA and other prostate investigations.
• Requires only a serum blood sample.
• Supports follow-up planning under specialist guidance.
• Provides laboratory-based information for clinical correlation.

Why Doctors Recommend This Test

Doctors may recommend this test for selected patients with a known prostate condition, previously diagnosed prostate cancer, suspected progression or recurrence, or those undergoing treatment monitoring. It may occasionally be ordered alongside PSA, imaging, biopsy findings, and clinical examination when additional biochemical information is considered useful.

Preparation Before Test

• No fasting is generally required unless instructed otherwise.
• A blood sample is collected and serum is used for testing.
• Inform your doctor about all medicines, vitamins, and supplements.
• Biotin-containing supplements may interfere with some laboratory methods and may need temporary restriction according to laboratory instructions.
• Do not stop medicines or supplements unless advised by your doctor.
• Inform the collector about any recent rectal examination, prostate massage, prostate biopsy, catheterisation, prostate surgery, or other prostate manipulation.
• Whenever possible, collect the sample before procedures involving manipulation of the prostate.
• Avoid strenuous activities that may affect the prostate if your doctor advises this.
• Share previous PSA, PAP, biopsy, imaging, and treatment reports if available.
• Follow the laboratory’s collection and timing instructions carefully.

Normal Reporting Time

The Acid Phosphatase – Prostatic Fraction test may require scheduled biochemical analysis and careful sample handling. Results are generally available within a few working days after sample receipt, processing, validation, and quality review. The exact reporting time may vary according to the testing method, schedule, sample condition, and laboratory workflow.

Who Should Take This Test?

This test may be recommended for:

• Patients with previously diagnosed prostate cancer.
• Individuals undergoing monitoring after prostate cancer treatment.
• Patients receiving androgen-deprivation therapy.
• Individuals being evaluated for possible disease progression or recurrence.
• Patients requiring additional prostate-related biochemical assessment.
• Individuals with abnormal PSA results when further evaluation is advised.
• Patients with suspicious prostate-imaging or examination findings.
• Individuals with advanced prostate disease under specialist care.
• Patients undergoing follow-up after prostate surgery.
• People specifically advised to undergo PAP testing by a urologist or oncologist.

Detailed Information

Acid phosphatase refers to a group of enzymes capable of removing phosphate groups from molecules in an acidic environment. These enzymes are present in several tissues, including the prostate, liver, spleen, blood cells, bone, and platelets. The prostatic fraction is associated primarily with secretory cells of the prostate gland.

Prostatic acid phosphatase may enter the bloodstream in increased amounts when prostate tissue is disrupted or affected by disease. Historically, high PAP concentrations were associated with prostate cancer, particularly disease extending beyond the prostate. However, PAP is not specific enough to diagnose malignancy by itself.

PAP has largely been replaced by prostate-specific antigen for routine prostate cancer screening and monitoring. PSA generally provides greater clinical sensitivity and more useful information. PAP may still have limited value in selected cases, particularly when interpreted with PSA, clinical findings, pathology, and imaging.

An elevated prostatic acid phosphatase result does not automatically indicate prostate cancer. Levels may also be affected by benign prostatic enlargement, inflammation, prostatic infarction, recent manipulation of the prostate, biopsy, surgery, or other clinical factors.

Procedures involving the prostate may temporarily increase PAP levels. These may include digital rectal examination, prostate massage, biopsy, surgery, or certain forms of instrumentation. The timing of sample collection in relation to these procedures should therefore be discussed with the doctor.

In patients with known prostate cancer, a rise in PAP may sometimes be associated with disease progression or recurrence. A reduction may be observed after effective treatment. However, biological variation and differences between laboratory methods limit the usefulness of interpreting small changes.

A normal PAP result does not exclude prostate cancer, including early or localised disease. Similarly, an elevated result cannot independently confirm cancer. Diagnosis requires clinical evaluation and may include PSA testing, digital rectal examination, prostate MRI, ultrasound, biopsy, histopathology, and other investigations.

Reference ranges can vary according to the analytical method used by the laboratory. Results should always be interpreted using the reference interval printed on the individual report rather than a general value obtained from another source.

Grossly haemolysed samples may interfere with testing because red blood cells contain acid phosphatase. Proper serum separation, storage, and transportation are therefore important for reliable analysis.

At Focus Diagnostics, Acid Phosphatase – Prostatic Fraction testing is processed using established biochemical methods, appropriate sample-handling procedures, and quality-assurance standards to provide reliable results for clinical interpretation.